The Patent Finder

HMR Pharma Inc.

Also on record
Records under this name other than patents HMR Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to HMR Pharma Inc.

PatentTitleStatus Expires Confidence
US 7,109,161Preserved pharmaceutical formulations
Formerly held
Term ended
Term ended Oct 14, 2021 · From the USPTO record
Term endedTerm ended Oct 14, 2021From the USPTO record
US 7,754,678Membrane Penetrating Peptides and Uses Thereof
Formerly held
Term ended
Term ended Aug 21, 2021 · High confidence
Term endedTerm ended Aug 21, 2021High confidence
US 6,576,647Pseudopolymorph of (—)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy -1-methyl)piperidinyl]-4H-1-benzopyran-4-one
Formerly held
Term ended
Term ended Jan 16, 2021 · From the USPTO record
Term endedTerm ended Jan 16, 2021From the USPTO record
US 6,229,014Spiro[cyclopent[b]indole-piperidines]
Formerly held
Term ended
Term ended Jul 24, 2020 · From the USPTO record
Term endedTerm ended Jul 24, 2020From the USPTO record
US 6,716,986Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-YL}-hydroxy-methyl)-2-methoxy-phenyl]ester
Formerly held
Term ended
Term ended Jul 13, 2020 · From the USPTO record
Term endedTerm ended Jul 13, 2020From the USPTO record
US 6,512,125Preparation of 1H-indol-1-amines
Formerly held
Term ended
Term ended Jan 28, 2020 · From the USPTO record
Term endedTerm ended Jan 28, 2020From the USPTO record
US 6,329,550Amidomalonamides useful as inhibitors of MMP of matrix metalloproteinase
Formerly held
Term ended
Term ended Dec 17, 2019 · From the USPTO record
Term endedTerm ended Dec 17, 2019From the USPTO record
US 6,352,976Selective inhibitors of MMP-12
Formerly held
Term ended
Term ended Dec 17, 2019 · From the USPTO record
Term endedTerm ended Dec 17, 2019From the USPTO record
US 6,486,1933-substituted pyrrolidines useful as inhibitors of matrix metalloproteinases
Formerly held
Term ended
Term ended Dec 17, 2019 · From the USPTO record
Term endedTerm ended Dec 17, 2019From the USPTO record
US 6,555,328Screening methods for altering circadian rhythms and for human casein kinase I &dgr; and/or &egr; phosphorylation of human clock proteins, period 1, -2 and -3
Formerly held
Term ended
Term ended Dec 14, 2019 · From the USPTO record
Term endedTerm ended Dec 14, 2019From the USPTO record
10 of 274 patents shown.
Pro members see all 274.
Pro members: see all 274 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited